Baird Financial Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,661
Closed -$147K 1812
2022
Q2
$147K Buy
+10,661
New +$147K ﹤0.01% 1724